drugset / Trial / NCT04738188

Efficacy and Safety of TACE on Downstaging Hepatocellular Carcinoma Beyond UCSF Criteria;

NCT04738188

RandomizedParallel-groupOpen-labelTreatment

Summary

This is a multicenter, randomized, parallel controlled study to determine the efficacy and safety of transcatheter arterial chemoembolization (TACE) on downstaging hepatocellular carcinoma beyond University of California, San Francisco (UCSF) criteria.

Timeline

Start
2020-03-18
Primary completion
2022-11
Completion
2025-12

Drugs

EvaluationDrugModalityDoseRoute
Background Epirubicin Small molecule Other